HDX and NMR Core
HDX and NMR Core
批准号:
10242903
负责人:
Patrick Robert Griffin
金额:
$104.57万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2023-08-31
关键词:
3-Dimensional5&apos Untranslated RegionsAchievementAddressAffectAffinityAmino Acid SequenceAnusBindingBinding SitesBiological ProcessC-terminalCollectionCommunicationComplexCryoelectron MicroscopyCustomDBL OncoproteinDNADataDatabasesDeuteriumDiseaseElderlyEnzyme InhibitionEvolutionFamilyFundingGoalsHIVHIV-1HIV-1 integraseHIV-1 proteaseHumanHydrogenIntegraseIntegrase InhibitorsIsotopesKineticsLengthLentivirusLigand BindingLigandsManuscriptsMass Spectrum AnalysisMolecular ConformationMolecular ProbesMotionNuclear Magnetic ResonanceNucleic AcidsPeptide FragmentsPolymerasePost-Translational Protein ProcessingPreparationProcessPropertyProtein ConformationProtein DynamicsProteinsRNARNA-Directed DNA PolymeraseReportingResearch PersonnelRoentgen RaysRoleSamplingScientistSpumavirusStructureTechniquesTechnologyTherapeutic InterventionThiophenesTransfer RNAViralVirusX-Ray Crystallographyaptamerbasedesigngag-pol Fusion Proteinsgenetic regulatory proteininhibitor/antagonistinnovationmembermolecular recognitionpol Gene Productsprotein complexprotein structureprototypequinolinereceptorresistance mutationsmall moleculetandem mass spectrometrytherapeutic proteintranscriptional coactivator p75viral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Proteins are dynamic molecules that undergo constant flexing and motion. Changes in protein conformation
and dynamics are important to molecular recognition and these changes occur during many key biological
processes including activation and inhibition of enzymes, ligand binding to receptors, posttranslational
modifications, and allosteric communication across protein-protein interfaces. All of these processes are
regulated through the structure and dynamics of the proteins within the functional complex. Thus, techniques to
study protein structure and dynamics are critical to the understanding of biological processes and to aid in
developing strategies to target proteins for therapeutic intervention in disease. The HDX-NMR Core will address
central goals of the HIVE Center that include characterization of HIV protein interactions among themselves,
with host molecules, or with small molecule probes. A key focus of HDX efforts will be the structure and dynamics
of the HIV-1 reverse transcriptase (RT) initiation complex, or RTIC, a large protein-nucleic acid complex
comprising RT (p66/p51 heterodimer), the primer-binding site region of the 5’ untranslated viral RNA (vRNA) and
a human tRNA (Project 3: Arnold, Musier-Forsyth, Griffin, Lyumkis, and Sarafianos). We will also investigate
the interactions of HIV-1 RT with members of the APOBEC3 (A3) family of restriction factors (most notably A3G),
which have been reported to suppress the polymerase activity of RT and will also be studied in Project 3. In
addition to the RTIC from lentivirus HIV-1, we will also investigate the RTIC of spumavirus prototype foamy virus
(PFV). We are taking a multifaceted approach towards understanding these important virus-host complex
interactions, using cryo-EM, X-ray crystallography, HDX, SAXS, and pre-steady state kinetic analyses. Among
the main questions addressable by HDX are: How does the vRNA/tRNA interact with RT compared to DNA/DNA
and DNA/RNA substrates (cryo-EM, X-ray, HDX, kinetics)? What is the role of RNA structure in this complex
and how does it interact with RT (cryo-EM, X-ray, HDX)? What are the dynamic properties of the initiation
complex (cryo-EM, SAXS, HDX, kinetics)? How do interactions in the HIV-1 and PFV RTICs differ? How does
HIV-1 RT interact with A3 proteins to contribute to HIV-1 restriction? HDX has been instrumental for studying
quinoline-based allosteric integrase (IN) inhibitor (ALLINIs) induced aberrant multimerization of full-length wild
type (WT) IN and its application will now be extended to examine how recently discovered (Core 4) thiophene-
based inhibitors alter the IN structure (Project 1). HDX-MS will also be used to probe inter-protein interactions
among HIV-1 Gag and Gag-Pol proteins (Project 2), the effect of resistance mutations or inter-clade differences
in inter-protein interactions in HIV-1 proteins (Project 5), and interactions between HIV-1 proteins and SuFEx or
other small molecule probes (Project 6). NMR will be used to support Project 6 and Core 4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantifying and modeling ligand-dependent control of RORγ dynamics via structural proteomics
-
批准号:10503840
-
项目类别:
-
资助金额:$59.28万
-
财政年份:2022
-
负责人:Patrick Robert Griffin
-
依托单位:
Quantifying and modeling ligand-dependent control of RORγ dynamics via structural proteomics
-
批准号:10704173
-
项目类别:
-
资助金额:$59.28万
-
财政年份:2022
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10426408
-
项目类别:
-
资助金额:$2.64万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10317378
-
项目类别:
-
资助金额:$67.81万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10634739
-
项目类别:
-
资助金额:$66.56万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9926588
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:9899246
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10357876
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10115706
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10581523
-
项目类别:
-
资助金额:$65.02万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
ALDH1a1 Inhibition As A Therapeutic Target In Visceral Adiposity and Type 2 Diabetes
-
批准号:10197108
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2017
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9526730
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9764509
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9125423
-
项目类别:
-
资助金额:$63.84万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Optimization of RORgamma-specific agonists as immune activators for a new immunotherapy approach for cancer
-
批准号:9244000
-
项目类别:
-
资助金额:$43.92万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Optimization of ERRg-specific ligands as in vivo Chemical Probes
-
批准号:9382901
-
项目类别:
-
资助金额:$39.84万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Molecular Characterization of Novel Insulin Sensitizers
-
批准号:9087254
-
项目类别:
-
资助金额:$58.27万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Molecular Characterization of Novel Insulin Sensitizers
-
批准号:8986841
-
项目类别:
-
资助金额:$60.57万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Development of RORbeta-selective modulators as in vivo probes
-
批准号:9088532
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
HDX and NMR Core
-
批准号:10363020
-
项目类别:
-
资助金额:$51.47万
-
财政年份:2012
-
负责人:Patrick Robert Griffin
-
依托单位:
国内基金
海外基金
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
-
批准号:81300507
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2013
-
负责人:陈黎
-
依托单位: